397 related articles for article (PubMed ID: 26603347)
1. Microneedle patches for vaccination in developing countries.
Arya J; Prausnitz MR
J Control Release; 2016 Oct; 240():135-141. PubMed ID: 26603347
[TBL] [Abstract][Full Text] [Related]
2. Rabies vaccination in dogs using a dissolving microneedle patch.
Arya JM; Dewitt K; Scott-Garrard M; Chiang YW; Prausnitz MR
J Control Release; 2016 Oct; 239():19-26. PubMed ID: 27524283
[TBL] [Abstract][Full Text] [Related]
3. Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development.
Adhikari BB; Goodson JL; Chu SY; Rota PA; Meltzer MI
Drugs R D; 2016 Dec; 16(4):327-338. PubMed ID: 27696306
[TBL] [Abstract][Full Text] [Related]
4. Microneedle Patches as Drug and Vaccine Delivery Platform.
Li J; Zeng M; Shan H; Tong C
Curr Med Chem; 2017; 24(22):2413-2422. PubMed ID: 28552053
[TBL] [Abstract][Full Text] [Related]
5. Dissolving Microneedle Patches for Dermal Vaccination.
Leone M; Mönkäre J; Bouwstra JA; Kersten G
Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
[TBL] [Abstract][Full Text] [Related]
6. [Development of transcutaneous vaccination system for infectious disease countermeasure].
Matsuo K
Yakugaku Zasshi; 2012; 132(12):1443-50. PubMed ID: 23208052
[TBL] [Abstract][Full Text] [Related]
7. Measles vaccination using a microneedle patch.
Edens C; Collins ML; Ayers J; Rota PA; Prausnitz MR
Vaccine; 2013 Jul; 31(34):3403-9. PubMed ID: 23044406
[TBL] [Abstract][Full Text] [Related]
8. Long-term stability of influenza vaccine in a dissolving microneedle patch.
Mistilis MJ; Joyce JC; Esser ES; Skountzou I; Compans RW; Bommarius AS; Prausnitz MR
Drug Deliv Transl Res; 2017 Apr; 7(2):195-205. PubMed ID: 26926241
[TBL] [Abstract][Full Text] [Related]
9. Engineering and characterisation of BCG-loaded polymeric microneedles.
Arshad MS; Fatima S; Nazari K; Ali R; Farhan M; Muhammad SA; Abbas N; Hussain A; Kucuk I; Chang MW; Mehta P; Ahmad Z
J Drug Target; 2020 Jun; 28(5):525-532. PubMed ID: 31718314
[TBL] [Abstract][Full Text] [Related]
10. Microneedle patches: usability and acceptability for self-vaccination against influenza.
Norman JJ; Arya JM; McClain MA; Frew PM; Meltzer MI; Prausnitz MR
Vaccine; 2014 Apr; 32(16):1856-62. PubMed ID: 24530146
[TBL] [Abstract][Full Text] [Related]
11. Dissolvable Microneedle Patches to Enable Increased Access to Vaccines against SARS-CoV-2 and Future Pandemic Outbreaks.
O'Shea J; Prausnitz MR; Rouphael N
Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33915696
[TBL] [Abstract][Full Text] [Related]
12. Design and characterisation of a dissolving microneedle patch for intradermal vaccination with heat-inactivated bacteria: A proof of concept study.
Rodgers AM; McCrudden MTC; Vincente-Perez EM; Dubois AV; Ingram RJ; Larrañeta E; Kissenpfennig A; Donnelly RF
Int J Pharm; 2018 Oct; 549(1-2):87-95. PubMed ID: 30048778
[TBL] [Abstract][Full Text] [Related]
13. Microneedle-mediated delivery of viral vectored vaccines.
Zaric M; Ibarzo Yus B; Kalcheva PP; Klavinskis LS
Expert Opin Drug Deliv; 2017 Oct; 14(10):1177-1187. PubMed ID: 27591122
[TBL] [Abstract][Full Text] [Related]
14. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
Ono A; Azukizawa H; Ito S; Nakamura Y; Asada H; Quan YS; Kamiyama F; Katayama I; Hirobe S; Okada N
Int J Pharm; 2017 Oct; 532(1):374-383. PubMed ID: 28855138
[TBL] [Abstract][Full Text] [Related]
15. Microneedle and mucosal delivery of influenza vaccines.
Kang SM; Song JM; Kim YC
Expert Rev Vaccines; 2012 May; 11(5):547-60. PubMed ID: 22697052
[TBL] [Abstract][Full Text] [Related]
16. Potential use of microarray patches for vaccine delivery in low- and middle- income countries.
Peyraud N; Zehrung D; Jarrahian C; Frivold C; Orubu T; Giersing B
Vaccine; 2019 Jul; 37(32):4427-4434. PubMed ID: 31262587
[TBL] [Abstract][Full Text] [Related]
17. Transcutaneous immunization of Streptococcus suis bacterin using dissolving microneedles.
Hsueh KJ; Chen MC; Cheng LT; Lee JW; Chung WB; Chu CY
Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():78-87. PubMed ID: 28131383
[TBL] [Abstract][Full Text] [Related]
18. A microneedle patch containing measles vaccine is immunogenic in non-human primates.
Edens C; Collins ML; Goodson JL; Rota PA; Prausnitz MR
Vaccine; 2015 Sep; 33(37):4712-8. PubMed ID: 25770786
[TBL] [Abstract][Full Text] [Related]
19. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.
Vassilieva EV; Kalluri H; McAllister D; Taherbhai MT; Esser ES; Pewin WP; Pulit-Penaloza JA; Prausnitz MR; Compans RW; Skountzou I
Drug Deliv Transl Res; 2015 Aug; 5(4):360-71. PubMed ID: 25895053
[TBL] [Abstract][Full Text] [Related]
20. Induction of CD8(+) T cell responses and protective efficacy following microneedle-mediated delivery of a live adenovirus-vectored malaria vaccine.
Pearson FE; O'Mahony C; Moore AC; Hill AV
Vaccine; 2015 Jun; 33(28):3248-55. PubMed ID: 25839104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
